NKGEN BIOTECH INC (NKGN)

US65488A1016 - Common Stock

0.64  +0.07 (+13.25%)

After market: 0.64 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023
Revenue
YoY % growth
EBITDA
YoY % growth
N/AN/AN/A-28.543M
EBIT
YoY % growth
-2.51M-2.74M
-9.16%		-29.746M
-985.62%
Operating Margin
N/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24
EPS
Q2Q % growth		N/AN/A
Revenue
Q2Q % growth		N/AN/A
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		N/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A